Similar articles

• Heparin-induced thrombocytopenia and thrombosis.

  Ananthasubramaniam K, Shurafa M, Prasad A. Ananthasubramaniam K, et al. Prog Cardiovasc Dis. 2000 Jan-Feb;42(4):247-60. doi: 10.1053/pcad.2000.0420247. Prog Cardiovasc Dis. 2000. PMID: 10661778 Review.
• Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis.

  Kramer R, Oberg-Higgins P, Russo L, Braxton JH. Kramer R, et al. Interact Cardiovasc Thorac Surg. 2009 Apr;8(4):439-41. doi: 10.1510/icvts.2008.193177. Epub 2009 Jan 7. Interact Cardiovasc Thorac Surg. 2009. PMID: 19129243
• Heparin-induced thrombocytopenia, a prothrombotic disease.

  Levy JH, Hursting MJ. Levy JH, et al. Hematol Oncol Clin North Am. 2007 Feb;21(1):65-88. doi: 10.1016/j.hoc.2006.11.003. Hematol Oncol Clin North Am. 2007. PMID: 17258119 Review.
• Heparin-induced thrombocytopenia and thrombosis syndrome after cardiopulmonary bypass.

  Holmes-Ghosh E. Holmes-Ghosh E. Am J Crit Care. 2000 Jul;9(4):276-8. Am J Crit Care. 2000. PMID: 10888150 Review. No abstract available.
• Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.

  Davenport A. Davenport A. Am J Kidney Dis. 2009 Aug;54(2):361-74. doi: 10.1053/j.ajkd.2009.03.012. Epub 2009 May 29. Am J Kidney Dis. 2009. PMID: 19481318 No abstract available.